Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1124]

Molecular profiling identifies new high-risk subtype of paediatric liver cancer

Molecular profiling identifies new high-risk subtype of paediatric liver cancer

Tumours on withdrawal: Amino acid deficiency shrinks childhood tumours

Tumours on withdrawal: Amino acid deficiency shrinks childhood tumours

Scientists identify new molecular strategies for tackling aggressive form of leukaemia

Scientists identify new molecular strategies for tackling aggressive form of leukaemia

AACR 2022: Some Latino children diagnosed with acute lymphoblastic leukaemia face higher risk of relapse compared to non-Latino white children

AACR 2022: Some Latino children diagnosed with acute lymphoblastic leukaemia face higher risk of relapse compared...

AACR 2022: Paediatric cancer patients in lower-and middle-income countries faced significantly higher mortality risk during the COVID-19 pandemic

AACR 2022: Paediatric cancer patients in lower-and middle-income countries faced significantly higher mortality...

The tumour cells of a type of childhood leukaemia block the formation of new neurones

The tumour cells of a type of childhood leukaemia block the formation of new neurones

Genetic ancestry matters in childhood leukaemia treatment success

Genetic ancestry matters in childhood leukaemia treatment success

Chronologically young and biologically old DNA linked to cancer survivors premature ageing

Chronologically young and biologically old DNA linked to cancer survivors premature ageing

Programme to offer molecular characterisation of childhood cancers

Programme to offer molecular characterisation of childhood cancers

FDA approves nivolumab and relatlimab-rmbw for unresectable or metastatic melanoma

FDA approves nivolumab and relatlimab-rmbw for unresectable or metastatic melanoma

More from ecancer